-
REDUCING FRAILTY IN OLDER ADULTS IN THE UK: ESTIMATED COST SAVINGS AND QUALITY-OF-LIFE BENEFITS
Aug 11, 2026, 17:16 PM -
HEALTH AND ECONOMIC IMPACT OF EXTENDING HPV VACCINATION TO ADULTS 20-26 YEARS OF AGE IN FRANCE: A MODELING STUDY
Aug 11, 2026, 17:16 PM -
IDENTIFYING FIT-FOR-PURPOSE OBSERVER REPORTED OUTCOMES BY CROSS COMPARING REGULATORY PERSPECTIVES AND VALIDITY EVIDENCE IN INTERCONNECTED DATABASES
Aug 11, 2026, 17:16 PM -
HEALTHCARE BURDEN ACROSS UACR AND KIDNEY FUNCTION CATEGORIES IN CHRONIC KIDNEY DISEASE: A REAL-WORLD STUDY IN ENGLAND (THE PROMISE STUDY)
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF ROBOTIC VERSUS LAPAROSCOPIC SURGERY IN COLORECTAL CANCER: REAL-WORLD EVIDENCE FROM A SPANISH TERTIARY HOSPITAL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PERIOPERATIVE PEMBROLIZUMAB FOR PATIENTS WITH RESECTABLE LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA IN GREECE
Aug 11, 2026, 17:16 PM -
ACCESS IS NOT ENOUGH: DIGITAL COMMUNICATION AND THE SOCIOECONOMIC GRADIENT IN OLDER ADULTS' HEALTH ACROSS SIX HARMONISED COHORTS
Aug 11, 2026, 17:16 PM -
LONG-TERM ECONOMIC IMPACT OF GENE THERAPY ETRANACOGENE DEZAPARVOVEC VERSUS EXTENDED HALF-LIFE FACTOR IX THERAPIES FOR SEVERE OR MODERATELY SEVERE HAEMOPHILIA B IN SPAIN
Aug 11, 2026, 17:16 PM -
CONTENT VALIDITY EVALUATION OF SELECTED PATIENT REPORTED OUTCOME MEASURES FOR PAIN, FATIGUE, AND PHYSICAL FUNCTIONING IN ADULTS, ADOLESCENTS AND CHILDREN LIVING WITH OSTEOGENESIS IMPERFECTA
Aug 11, 2026, 17:16 PM -
THE SOCIO-ECONOMIC BURDEN OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN ITALY: RESULTS FROM A REAL-WORLD SURVEY
Aug 11, 2026, 17:16 PM -
CHARACTERIZING REAL-WORLD DATA AVAILABILITY FOR MONITORING ANTI-AMYLOID THERAPY IN ALZHEIMER'S DISEASE
Aug 11, 2026, 17:16 PM -
ESTABLISHING A MULTI-STAKEHOLDER CONSENSUS FRAMEWORK FOR INNOVATIVE MEDICAL DEVICE MARKET ACCESS AND HTA INTEGRATION IN THE MENA REGION
Aug 11, 2026, 17:16 PM -
NICE'S APPROACH TO TRIAGING AI USE CASES TO EXPLORE POTENTIAL USE FOR GUIDANCE PRODUCTION TASKS
Aug 11, 2026, 17:16 PM -
MORE DATA, MORE FLEXIBILITY? EVALUATING AN ONCOLOGY SURVIVAL MODEL SELECTION ALGORITHM ACROSS SEQUENTIAL TRIAL DATA CUTS
Aug 11, 2026, 17:16 PM -
CLINICAL, ECONOMIC, AND HUMANISTIC BURDEN OF ELEVATED LIPOPROTEIN(A) IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
SPOTLIGHT ON SJOGREN'S: DISEASE BURDEN AND UNMET NEEDS FOR PATIENTS IN THE UNITED KINGDOM (UK)
Aug 11, 2026, 17:16 PM -
EARLY EVIDENCE PICO MULTIPLICITY UNDER THE EU HTAR: INSIGHTS FROM THE INAUGURAL JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
ESCALATING DRUG COSTS OF MYELOFIBROSIS TREATMENT IN A COLOMBIAN HEALTH INSURANCE COMPANY: EVIDENCE FROM RUXOLITINIB DISPENSING RECORDS (2022-2026)
Aug 11, 2026, 17:16 PM -
ONE NATIONAL PROTOCOL, MANY LOCAL REALITIES: A REAL-WORLD ANALYSIS OF THE ADRENAL INSUFFICIENCY CLINICAL GUIDELINE IN BRAZIL'S UNIFIED HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
POTENTIAL PATIENT OPPORTUNITY LOSS ASSOCIATED WITH DELAYED AND ABSENT ACCESS TO NEWLY APPROVED MEDICINES IN FRANCE: A CROSS-COUNTRY ANALYSIS
Aug 11, 2026, 17:16 PM
